Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Change in cumulative translation adjustment
Accumulated Other Comprehensive Income (Loss)
Equity of Non-controlling Interest
Change in cumulative translation adjustment
Total
Stockholders' equity, Beginning balance at Jan. 30, 2021 $ 130 $ 474,375 $ (447,455)         $ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021 13,019,061              
Net loss     (3,228)     $ (150)   (3,378)
Common stock issuances pursuant to equity compensation awards $ 1 (262)           (261)
Common stock issuances pursuant to equity compensation awards (in shares) 76,341              
Share-based payment compensation   668           668
Common stock and warrant issuance $ 33 21,191           21,224
Common stock and warrant issuance (in shares) 3,289,000              
Investment of non-controlling interest           3,430   3,430
Stockholders' equity, ending balance at May. 01, 2021 $ 164 495,972 (450,683)     3,280   48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021 16,384,402              
Net loss     (4,249)     (132)   (4,381)
Common stock issuances pursuant to equity compensation awards (in shares) 39,094              
Share-based payment compensation   768           768
Common stock and warrant issuance $ 48 40,095           40,143
Common stock and warrant issuance (in shares) 4,830,918              
Stockholders' equity, ending balance at Jul. 31, 2021 $ 212 536,835 (454,932)     3,148   85,263
Common Stock, Shares, Outstanding period end at Jul. 31, 2021 21,254,414              
Net loss     (9,492)         (9,492)
Common stock issuances pursuant to equity compensation awards $ 1 67           68
Common stock issuances pursuant to equity compensation awards (in shares) 306,100              
Share-based payment compensation   949           949
Common stock and warrant issuance   136           136
Other Comprehensive Income (loss)         $ (371)     (371)
Stockholders' equity, ending balance at Oct. 30, 2021 $ 213 537,987 (464,424)   (371) 3,148   76,553
Common Stock, Shares, Outstanding period end at Oct. 30, 2021 21,560,514              
Stockholders' equity, Beginning balance at Jan. 29, 2022 $ 216 538,627 (469,463)   (2,428) 2,412   $ 69,363
Common Stock, Shares, Outstanding period beginning at Jan. 29, 2022 21,571,387             21,571,387
Net loss     (11,896)     (319)   $ (12,215)
Common stock issuances pursuant to equity compensation awards $ 2 (212)           (210)
Common stock issuances pursuant to equity compensation awards (in shares) 232,630              
Share-based payment compensation   985           985
Stockholders' equity, ending balance at Apr. 30, 2022 $ 218 539,400 (481,359) $ (4,275) (6,703) 2,093 $ (4,275) 53,649
Common Stock, Shares, Outstanding period end at Apr. 30, 2022 21,804,017              
Net loss     (12,691)     (96)   (12,787)
Common stock issuances pursuant to equity compensation awards $ 2 (13)           (11)
Common stock issuances pursuant to equity compensation awards (in shares) 177,550              
Share-based payment compensation   1,123           1,123
Divestiture of Business           $ (1,997)   (1,997)
Common stock and warrant issuance $ 35 18,438           18,473
Common stock and warrant issuance (in shares) 3,500,822              
Stockholders' equity, ending balance at Jul. 30, 2022 $ 255 558,948 (494,050) $ (3,401) (10,104)   $ (3,401) 55,049
Common Stock, Shares, Outstanding period end at Jul. 30, 2022 25,482,389              
Net loss     (21,298)         (21,298)
Common stock issuances pursuant to equity compensation awards   107           107
Common stock issuances pursuant to equity compensation awards (in shares) 10,554              
Share-based payment compensation   1,097           1,097
Common stock and warrant issuance $ 2 1,558           1,560
Common stock and warrant issuance (in shares) 3,423,904              
Other Comprehensive Income (loss)         (1,039)     (1,039)
Stockholders' equity, ending balance at Oct. 29, 2022 $ 257 $ 561,710 $ (515,348)   $ (11,143)     $ 35,476
Common Stock, Shares, Outstanding period end at Oct. 29, 2022 28,916,847             28,916,847